Cancer proteomics: from bench to bedside
2008
Cancer Proteomics: From Bench to Bedside
publication
Evidence: low
Author Information
Author(s): Timms J F
Primary Institution: University College London
Conclusion
The book provides a broad overview of cancer proteomics but highlights that clinical proteomics is still in its infancy with little clinical validation of biomarkers.
Supporting Evidence
- The book covers various methodologies and strategies for biomarker discovery.
- It discusses the inadequacies of currently used serum tumor markers.
- The book highlights the need for better cancer biomarkers.
Takeaway
This book talks about how scientists study proteins to help find and treat cancer, but it shows that we still have a long way to go before these studies help patients.
Limitations
The book reveals that clinical proteomics is still in its infancy and that biomarker research is in the early discovery phase with little clinical validation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website